Professional Documents
Culture Documents
Corticosteroid Injection For de Quervain's Tenosynovitis (Review)
Corticosteroid Injection For de Quervain's Tenosynovitis (Review)
www.cochranelibrary.com
Cyriac Peters-Veluthamaningal1 , Daniëlle AWM van der Windt2 , Jan C Winters1 , Betty Meyboom-de Jong1
1 Department of General Practice, University Medical Center Groningen, Groningen, Netherlands. 2 EMGO Institute and Department
Contact address: Cyriac Peters-Veluthamaningal, Department of General Practice, University Medical Center Groningen, Antonius
Deusinglaan 1, Groningen, 9713 AV, Netherlands. raju@dds.nl.
Citation: Peters-Veluthamaningal C, van der Windt DAWM, Winters JC, Meyboom-de Jong B. Corticosteroid injec-
tion for de Quervain’s tenosynovitis. Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD005616. DOI:
10.1002/14651858.CD005616.pub2.
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
ABSTRACT
Background
De Quervain’s tenosynovitis is a disorder characterised by pain on the radial (thumb) side of the wrist and functional disability of the
hand. It can be treated by corticosteroid injection, splinting and surgery.
Objectives
To summarise evidence on the efficacy and safety of corticosteroid injections for de Quervain’s tenosynovitis.
Search methods
We searched the following databases: the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2009,
Issue 2), MEDLINE (1966 to April 2009), EMBASE (1956 to April 2009), CINAHL (1982 to April 2009), AMED (1985 to April
2009), DARE, Dissertation Abstracts and PEDro (physiotherapy evidence database).
Selection criteria
Randomised and controlled clinical trials evaluating the efficacy and safety of corticosteroid injections for de Quervain’s tenosynovitis.
Data collection and analysis
After screening abstracts of studies identified by the search we obtained full text articles of studies which fulfilled the selection criteria.
We extracted data using a predefined electronic form. We assessed the methodological quality of included trials by using the checklist
developed by Jadad and the Delphi list. We extracted data on the primary outcome measures: treatment success; severity of pain or
tenderness at the radial styloid; functional impairment of the wrist or hand; and outcome of Finkelstein’s test, and the secondary
outcome measures: proportion of patients with side effects; type of side effects and patient satisfaction with injection treatment.
Main results
We found one controlled clinical trial of 18 participants (all pregnant or lactating women) that compared one steroid injection with
methylprednisolone and bupivacaine to splinting with a thumb spica. All patients in the steroid injection group (9/9) achieved complete
relief of pain whereas none of the patients in the thumb spica group (0/9) had complete relief of pain, one to six days after intervention
(number needed to treat to benefit (NNTB) = 1, 95% confidence interval (CI) 0.8 to 1.2). No side effects or local complications of
steroid injection were noted.
Corticosteroid injection for de Quervain’s tenosynovitis (Review) 1
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Authors’ conclusions
The efficacy of corticosteroid injections for de Quervain’s tenosynovitis has been studied in only one small controlled clinical trial,
which found steroid injections to be superior to thumb spica splinting. However, the applicability of our findings to daily clinical
practice is limited, as they are based on only one trial with a small number of included participants, the methodological quality was
poor and only pregnant and lactating women participated in the study. No adverse effects were observed.
This summary of a Cochrane review presents what we know from research about the effect of Corticosteroid injections for de Quervain’s
tenosynovitis.
We are uncertain whether Corticosteroid injections reduces pain because of the very low quality of the evidence.
De Quervain’s tenosynovitis occurs when the tendon in your thumb and wrist becomes inflammed, painful and difficult to move.
A tendon is the part of your body that connects your muscles to your bones. People with de Quervain’s tenosynovitis have pain,
tenderness, and swelling at the base of the thumb, especially when moving their wrist from side to side.
Corticosteroid injections are shots with a needle into a joint (such as your wrist) or a tendon. Corticosteroids may work by reducing
the inflammation of your wrist or thumb. The injection itself might also help to relieve the pressure on the tendon.
Quality appraisal
Primary outcomes
Two review authors independently extracted all data. We assessed
• Treatment success: yes or no (we anticipated that the
each trial using a combination of an established quality assess-
definition of treatment success may vary across trials).
ment tool developed by Jadad (Jadad 1996) and the Delphi list
• Severity of pain or tenderness at the radial styloid.
(Verhagen 1998). The quality items assessed were:
• Finkelstein’s test negative: yes or no.
1. randomisation;
• Functional status of the finger (using validated instruments
2. concealment of allocation;
to measure hand function).
3. blinding of outcome assessor, care provider and patient;
• Proportion of patients with adverse effects of steroid
4. reporting of withdrawals and drop-outs;
injection.
5. similarity of groups at baseline regarding the most
important prognostic indicators;
6. specification of eligibility criteria;
Secondary outcomes 7. availability of point estimates and measures of variability of
• Patient satisfaction (using validated questionnaires). primary outcome measures;
8. use of intention-to-treat analysis.
Each criterion was rated as adequate, inadequate or unclear (if
insufficient information was presented).
Search methods for identification of studies
We searched the following electronic databases: Data extraction
• the Cochrane Central Register of Controlled Trials
(CENTRAL) (The Cochrane Library 2009, Issue 2); Two authors extracted details of the study population, interven-
• MEDLINE (1966 to April 2009, Ovid platform); tions, treatment periods, length of follow up, complications, base-
• EMBASE (1956 to April 2009, Ovid platform); line demographic data and baseline and end of study outcomes
• CINAHL (1982 to April 2009, Ovid platform); using a pre-defined electronic form. We arbitrarily defined short-
• AMED (1985 to April 2009, Ovid platform); term outcomes as outcomes up to three months after the interven-
• PEDro, the physiotherapy evidence database ( tion and long-term outcomes as outcomes one year post-interven-
www.pedro.org.au) tion or later. Referring back to the original article and establishing
• DARE (the Database of Abstracts of Reviews of consensus resolved differences in data extraction. We consulted a
Effectiveness; via The Cochrane Library 2009, Issue 2); third author to help resolve differences.
• Dissertation abstracts.
The search strategy was developed for MEDLINE and modified Data analysis
as necessary for the other databases. For continuous data, we planned to calculate mean differences
Complete search strategies for each database are provided in (MD) for outcomes measured using the same scale, and when the
Appendix 1; Appendix 2; Appendix 3; Appendix 4; Appendix 5; same outcomes were measured using different scales we were to
Appendix 6; Appendix 7; Appendix 8. We checked the references use standardised mean differences (SMD). We planned to calcu-
of all relevant publications (RCTs and reviews) to identify addi- late absolute and relative difference in the change from baseline
tional trials. We contacted content experts for unpublished data. for continuous outcomes. We were to calculate absolute benefit as
There were no language restrictions. the improvement in the treatment group minus the improvement
REFERENCES
Avci 2002
Interventions Group 1: 1 injection of 0.25 ml methylprednisolone (10 mg) with 0.5% bupivacaine into the tendon
sheath
Group 2: thumb spica splints worn during daytime
Outcomes Definition of treatment success: complete relief of pain and a negative Finkelstein test result
Notes -
Risk of bias
Goldfarb 2007 Not comparison of interest: injection with steroid, lidocaine and bupivacaine alone was compared to
injection with steroid, lidocaine, bupivacaine and bicarbonate
Jirarattanaphochai 2004 Not comparison of interest: steroid injection was compared to steroid injection with additional oral
medication
Kosuwon 1996 Not comparison of interest: steroid injection was compared to steroid injection followed by wrist immo-
bilisation in a splint
Peters 2007
Trial name or title The Groningen Hand and Wrist Injection Therapy Trial
Outcomes 1. Direct treatment response (consensus between physician and patient): no response; partial response,
but not satisfactory, warranting further treatment; partial response, satisfactory, not warranting further
treatment; complete resolution of symptoms and signs)
2. Perceived improvement (by patient): much worse, worse, not better/not worse, better, much better
3. Severity of pain at the radial styloid: 11-point numeric rating scale: 0 to 10
4. Functional improvement using the sub-items hand and finger function of the Dutch version of the
second version of the Arthritis Impact Measurement Scale (DUTCH AIMS-2)
Contact information Cyriac Peters-Veluthamaningal, general practitioner. Department of General Practice, University Medical
Center Groningen, Antonius Deusiglaan 1, 9713 AV Groningen, the Netherlands. E-mail: raju@dds.nl
Notes -
Comparison 1. 0.25 ml of methylprednisolone (10 mg) + 0.5% bupivacaine vs thumb spica splint
No. of No. of
Outcome or subgroup title studies participants Statistical method Effect size
1 Complete relief of symptoms 1 Risk Difference (M-H, Random, 95% CI) Subtotals only
Analysis 1.1. Comparison 1 0.25 ml of methylprednisolone (10 mg) + 0.5% bupivacaine vs thumb spica
splint, Outcome 1 Complete relief of symptoms.
Comparison: 1 0.25 ml of methylprednisolone (10 mg) + 0.5% bupivacaine vs thumb spica splint
-2 -1 0 1 2
Favours splint Favours injection
Outcome n Patients/ n Control event Absolute RD Relative % NNTB [95% Statistical Quality of ev-
Trials rate [95% CI] change CI] significance idence
APPENDICES
HISTORY
Protocol first published: Issue 1, 2006
Review first published: Issue 3, 2009
CONTRIBUTIONS OF AUTHORS
CP: main author
DW: text of review, data extraction and analysis
JW: data extraction and analysis
BM: selection of studies
DECLARATIONS OF INTEREST
CP has conducted a randomised controlled trial (Groningen Hand and Wrist Injection Therapy Trial - HAWITT) assessing the
efficacy and safety of corticosteroid injections for trigger finger, de Quervain’s tenosynovitis and carpal tunnel syndrome in a primary
care population. The HAWITT-trial is sponsored by an unrestricted educational grant by the pharmaceutical company Bristol-Myers
Squibb.
Internal sources
• Department of General Practice, University Medical Center Groningen, Netherlands.
• EMGO Institute, VU University Medical Center Amsterdam, Netherlands.
External sources
• No sources of support supplied
INDEX TERMS